GlassScriptPhysician profile
Jack Nils Benson
NPI 1972512655
$614.88
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $99.13 · 2021: $16.00 · 2022: $15.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $168.99 | 2019-2020 | |
| Pfizer INC. | $71.11 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $60.13 | 2019 | |
| Abbvie INC. | $59.93 | 2019-2021 | |
| Amgen INC. | $53.25 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $42.24 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $31.60 | 2019-2020 | |
| Blue Earth Diagnostics | $30.01 | 2019 | |
| Coloplast Corp | $19.38 | 2020 | |
| Neotract INC. | $18.07 | 2019 | |
| Astellas Pharma US INC | $16.05 | 2020 | |
| Boston Scientific Corporation | $15.99 | 2022 | |
| Photocure INC | $14.59 | 2019 | |
| Janssen Biotech, INC. | $13.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.